- About UsOur Story, Our Team & Support Information
- What We DoAdvocacy to Achieve the End of AIDS
- Advance HIV/SRH Integration
- Advocate for Access to High-Impact Prevention
- Improve Research Conduct
- Product Innovation & Availability
- Promote Effective HIV Prevention Policy
- Strengthen Global Advocacy Networks
- Track and Translate the Field
- Our FocusInterventions to End the Epidemic
- ResourcesPublications, Infographics, Events & More
- MediaInformation & Resources for the Press
- Our BlogPrevention News & Perspective
February 5, 2015
Report co-author, Dr Mary Moran, and international key commentators discussed the report's findings and health funding decisions for the future. The first G-FINDER Reproductive Health survey reported 2013 global investment into research and development (R&D) for new reproductive health products for developing countries. It covered investment for post-partum haemorrhage, contraceptives, non-HIV STIs, multipurpose prevention technologies and platform technologies. The G-FINDER Reproductive Health survey is conducted by the independent research group Policy Cures and is funded by the Bill & Melinda Gates Foundation. For more information regarding G-FINDER and Policy Cures, visit www.policycures.org or contact info@policycures.org.
Link
Location
PATH, 455 Massachusetts Ave. NW, Suite 1000, Washington, DC 20001
Speakers
Mary Moran
Policy Cures
Jane Hutchings
PATH
Judy Manning
USAID
Gates Foundation